Ok
Cancel
Don't show this message again
-
Ok CancelDon't show this message again
Coming Drug Price Transparency Requirements and Compliance Implications
Jeffrey Lewis, Director of Compliance, Rx Savings Solution.
Tricia Beckmann, Director, Faegre Drinker Biddle & Reath.
2023-02-02
-
Survey the current regulatory landscape and the underlying needs for drug price transparency
-
Understand how to comply with new CMS regulations for commercial and Medicare plans with RTBTs
-
How RTBTs create savings and curb high costs incurred by plans and beneficiaries
-